ACB — Aurora Cannabis Inc.Healthcare · Drug Manufacturers - Specialty & GenericTSX

CAD 274.3M

Mkt Cap

CAD 241.0M

Ent. Value

CAD 33.3M

Net Cash

CAD 4.64

52W CAD 4 – CAD 9

CAD 274.3M

Mkt Cap

CAD 241.0M

Ent. Value

CAD 33.3M

Net Cash

N/M

P/E TTM

—

PEG

—

P/FCF

0.5×

P/Book

0.7×

P/Sales

4.7×

EV/EBITDA

24.2×

EV/EBIT

—

EV/FCF

0.7×

EV/Sales

-30.8%

Earn Yld

-11.4%

FCF Yld

—

Div Yld

CAD 4.64

All values in Canadian Dollars (CAD)

CAD	FY2025	FY2024	FY2022	FY2021
Revenue	343.29M	269.64M	221.34M	245.25M
YoY Growth	+27.3%	+21.8%	-9.8%	—
Gross Profit	187.61M	131.73M	21.23M	(21.56M)
Gross Margin	54.6%	48.9%	9.6%	-8.8%
R&D	3.68M	3.57M	10.39M	11.45M
SG&A	166.47M	155.95M	188.99M	194.88M
EBIT	9.97M	(31.05M)	(219.38M)	(246.65M)
EBIT Margin	2.9%	-11.5%	-99.1%	-100.6%
D&A	22.55M	32.77M	93.66M	98.08M
EBITDA	51.35M	(11.06M)	(1.55B)	(535.28M)
EBITDA Margin	15.0%	-4.1%	-702.4%	-218.3%
Net Income	1.59M	(69.33M)	(1.72B)	(693.63M)
Net Margin	0.5%	-25.7%	-776.0%	-282.8%
EPS (diluted)	CAD 0.04	-CAD 1.52	-CAD 79.90	-CAD 41.00
Shares (dil., M)	55	43	21	17

Company Brief

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

CEOMr. Miguel MartinIPO Date2016-10-05CountryCanadaWebsitewww.auroramj.com

Margins (TTM)

Gross Margin	36.0%
EBITDA Margin	-12.9%
EBIT Margin	-14.9%
Net Margin	-22.7%
FCF Margin	-8.4%

Returns on Capital

ROIC	-8.3%
ROCE	-7.5%
ROE	-14.9%
ROA	-9.9%
Asset Turnover	0.44×

Earnings Quality

FCF / Net Income	-179.4%
SBC / Net Income	724.3%
SBC / Revenue	3.4%
Capex / D&A	0.84×

Growth (CAGR)

Metric	3yr
Revenue	11.9%
EPS	—
FCF	—
Dividend	—

Ownership

Float	95.4%
Shares Out.	59.1M
Insiders %	0.0%
Institutions %	13.1%
Institutions (of float)	13.1%
Institution holders	199
Insider net buy 6M	—

Similar Stocks

4BB AAWH.U AB ABNX ABSI ABUS

Balance Sheet

Cash & ST Invest.	CAD 138.5M
Total Debt	CAD 104.6M
Net Cash / (Debt)	CAD 33.3M
Total Assets	CAD 852.7M
Total Equity	CAD 567.2M
Goodwill & Intang.	CAD 89.0M
Tangible Book Value	CAD 478.1M
NCAV (Graham)	CAD 192.8M
Tangible Book/sh	CAD 8.09
NCAV/sh	CAD 3.26

Leverage

D/E Ratio	0.18×
Net Debt / EBITDA	0.69×
Interest Coverage	-6.45×
Current Ratio	4.31×
Quick Ratio	2.16×

Capital Allocation (last FY)

Capex	CAD 18.9M
Capex / Revenue	5.5%
SBC	CAD 11.5M
Dividends Paid	—
Buybacks	—

Dividends

No dividend paid.

Valuation vs History

P/E vs 4Y	N/Mvs 109.7× median
Div yield vs 10Y	—

Buyback History

FY 2025—+3.1%

FY 2024—+83.2%

FY 2022—+50.3%

FY 2021——

Margins (TTM)

Gross Margin	36.0%
EBITDA Margin	-12.9%
EBIT Margin	-14.9%
Net Margin	-22.7%
FCF Margin	-8.4%

Returns on Capital

ROIC	-8.3%
ROCE	-7.5%
ROE	-14.9%
ROA	-9.9%
Asset Turnover	0.44×

Earnings Quality

FCF / Net Income	-179.4%
SBC / Net Income	724.3%
SBC / Revenue	3.4%
Capex / D&A	0.84×

Growth (CAGR)

Metric	3yr
Revenue	11.9%
EPS	—
FCF	—
Dividend	—

Ownership

Float	95.4%
Shares Out.	59.1M
Insiders %	0.0%
Institutions %	13.1%
Institutions (of float)	13.1%
Institution holders	199
Insider net buy 6M	—

Similar Stocks

4BB AAWH.U AB ABNX ABSI ABUS

CAD 4.64

All values in Canadian Dollars (CAD)

CAD	FY2025	FY2024	FY2022	FY2021
Revenue	343.29M	269.64M	221.34M	245.25M
YoY Growth	+27.3%	+21.8%	-9.8%	—
Gross Profit	187.61M	131.73M	21.23M	(21.56M)
Gross Margin	54.6%	48.9%	9.6%	-8.8%
R&D	3.68M	3.57M	10.39M	11.45M
SG&A	166.47M	155.95M	188.99M	194.88M
EBIT	9.97M	(31.05M)	(219.38M)	(246.65M)
EBIT Margin	2.9%	-11.5%	-99.1%	-100.6%
D&A	22.55M	32.77M	93.66M	98.08M
EBITDA	51.35M	(11.06M)	(1.55B)	(535.28M)
EBITDA Margin	15.0%	-4.1%	-702.4%	-218.3%
Net Income	1.59M	(69.33M)	(1.72B)	(693.63M)
Net Margin	0.5%	-25.7%	-776.0%	-282.8%
EPS (diluted)	CAD 0.04	-CAD 1.52	-CAD 79.90	-CAD 41.00
Shares (dil., M)	55	43	21	17

Company Brief

CEOMr. Miguel MartinIPO Date2016-10-05CountryCanadaWebsitewww.auroramj.com

Balance Sheet

Cash & ST Invest.	CAD 138.5M
Total Debt	CAD 104.6M
Net Cash / (Debt)	CAD 33.3M
Total Assets	CAD 852.7M
Total Equity	CAD 567.2M
Goodwill & Intang.	CAD 89.0M
Tangible Book Value	CAD 478.1M
NCAV (Graham)	CAD 192.8M
Tangible Book/sh	CAD 8.09
NCAV/sh	CAD 3.26

Leverage

D/E Ratio	0.18×
Net Debt / EBITDA	0.69×
Interest Coverage	-6.45×
Current Ratio	4.31×
Quick Ratio	2.16×

Capital Allocation (last FY)

Capex	CAD 18.9M
Capex / Revenue	5.5%
SBC	CAD 11.5M
Dividends Paid	—
Buybacks	—

Dividends

No dividend paid.

Valuation vs History

P/E vs 4Y	N/Mvs 109.7× median
Div yield vs 10Y	—

Buyback History

FY 2025—+3.1%

FY 2024—+83.2%

FY 2022—+50.3%

FY 2021——

Not investment adviceUpdated 4/17/2026